Solesence, Inc.

SLSN Consumer Defensive Household & Personal Products

Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.02 0.00 0.00%
Market cap
$70.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
1.02
Beneish M
−1.13
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
82.90 37.48 0.00 0.00 79.71 34.55 0.00 0.00 0.00 0.00
Piotroski F-Score
2 7 1 1 6 4 2 1 2 3
P/S ratio
1.81 2.91 0.80 1.49 6.72 1.89 0.82 1.74 1.31 2.06
Altman Z-Score
1.02 1.26 (3.08) (1.99) 2.39 (6.71) (13.84) (16.63) (16.07) (19.03)
P/FCF ratio
0.00 0.00 0.00 0.00 443.16 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(3.70) (4.94) (10.89) (9.42) (9.22) (22.02) (36.45) (49.25) (46.76) (61.33)
Beneish M-Score
(1.13) (2.07) (3.16) (2.49) (0.88) (0.36) 37.53 (3.35) (1.23) (3.76)
P/Operating CF
61.87 69.50 (11.22) 74.30 96.54 (98.59) (16.66) (58.73) (173.35) 196.96
P/B ratio
7.99 10.18 15.63 9.83 26.54 11.87 6.78 17.87 5.04 7.97
Price to Tangible BV
7.99 10.18 15.63 9.83 26.54 11.87 6.78 17.87 5.04 7.97
EV/Sales
2.04 3.09 1.04 1.65 6.77 1.99 0.85 1.73 1.20 1.93
EV/EBITDA
51.25 26.72 0.00 0.00 50.93 16.18 0.00 0.00 0.00 0.00
EV/Operating CF
(14.77) 82.15 (19.35) (37.33) 85.93 (16.56) (3.84) (18.32) (15.58) (86.26)
EV/FCF
(11.81) (62.59) (12.70) (13.77) 446.18 (11.62) (3.03) (16.37) (14.49) (51.20)
Quick Ratio
0.58 0.24 0.33 0.50 0.63 0.57 0.49 0.60 1.52 1.71
Current Ratio
2.07 1.14 1.05 1.20 1.58 1.30 1.13 1.29 2.28 2.64
Net Debt/EBITDA
5.66 0.59 (3.24) (3.60) 0.09 0.81 (0.17) 0.20 3.60 2.54
Debt/Assets
30.50% 10.00% 32.88% 24.68% 3.54% 19.64% 17.26% 15.31% 6.64% 2.27%
Debt/Equity
0.87 0.33 5.68 1.47 0.13 0.97 1.07 0.73 0.13 0.04
Asset Turnover
1.24 1.26 1.12 1.20 1.41 1.49 1.57 2.21 2.25 2.29
Operating CF/Net income
(4.79) 0.47 0.46 0.63 1.00 (2.08) 0.92 0.64 1.22 0.19
Capex/Depreciation
(2.39) (4.91) (1.42) (4.98) (1.38) (1.40) (2.14) (0.50) (0.21) (0.27)
Interest Coverage
1.69 7.66 (4.23) (5.91) 2.22 2.99 (13.31) (34.88) (22.71) (84.53)
ROE
10.99% 50.27% (116.28%) (40.00%) 45.50% 46.62% (207.67%) (90.16%) (26.20%) (45.40%)
ROA
3.58% 10.22% (13.22%) (8.47%) 11.07% 8.63% (37.71%) (32.43%) (14.21%) (27.25%)
ROIC
3.11% 17.30% (20.17%) (12.02%) 20.47% 20.93% (90.31%) (120.99%) (28.50%) (70.63%)
Return on Tangible Assets
6.14% 25.97% (46.80%) (24.42%) 25.86% 20.11% (106.18%) (71.34%) (18.68%) (36.40%)
Average Days of Receivables
40.20 33.95 33.93 46.30 48.75 62.50 28.30 21.32 32.63 14.69
Research and Development Expense of Revenue
6.59% 7.33% 10.29% 8.14% 7.58% 9.17% 14.95% 14.49% 13.92% 14.41%
Selling, General and Administrative Expense of Revenue
16.76% 13.79% 20.20% 20.32% 13.22% 17.13% 28.32% 22.94% 23.14% 27.39%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.93% 1.38% 2.07% 1.67% 0.54% 1.14% 1.93% 1.44% 1.47% 1.92%
Graham Net Nets
(0.06) (0.04) (0.49) (0.20) (0.05) (0.06) (0.28) (0.02) 0.10 0.06
Graham Number
0.29 0.59 0.00 0.00 0.45 0.20 0.00 0.00 0.00 0.00
Earnings Yield
1.21% 2.67% (13.88%) (4.69%) 1.25% 2.89% (30.39%) (8.41%) (4.73%) (5.39%)
Free Cash Flow Yield
(9.52%) (1.70%) (10.28%) (8.06%) 0.23% (9.06%) (34.31%) (6.07%) (6.33%) (1.82%)
Revenue per Share
0.88 0.84 0.75 0.76 0.65 0.45 0.34 0.42 0.40 0.35
Operating CF per Share
(0.12) 0.03 (0.04) (0.03) 0.05 (0.05) (0.08) (0.04) (0.03) (0.01)
Capex per Share
(0.03) (0.07) (0.02) (0.06) (0.04) (0.02) (0.02) 0.00 0.00 (0.01)
Free Cash Flow per Share
(0.15) (0.04) (0.06) (0.09) 0.01 (0.08) (0.10) (0.04) (0.03) (0.01)
Cash per Share
0.02 0.02 0.03 0.04 0.01 0.03 0.03 0.04 0.06 0.06
Shareholders Equity per Share
0.25 0.24 0.04 0.12 0.17 0.07 0.04 0.04 0.10 0.09
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.25 0.24 0.04 0.12 0.17 0.07 0.04 0.04 0.10 0.09
Free Cash Flow
(10.71) (2.59) (3.06) (4.47) 0.45 (2.94) (3.52) (1.50) (1.03) (0.41)
Working Capital
14.85 3.58 0.71 2.79 4.26 2.05 0.58 1.05 2.60 2.13
Capital Expenditures
(2.14) (4.56) (1.05) (2.82) (1.87) (0.88) (0.74) (0.16) (0.07) (0.16)
Net Current Asset Value
(3.64) (5.71) (14.68) (11.28) (9.33) (1.97) (2.88) (0.50) 1.59 1.38
EV/EBIT
80.49 31.55 0.00 0.00 77.94 22.99 0.00 0.00 0.00 0.00
Capex to Sales
0.03 0.09 0.03 0.08 0.06 0.05 0.06 0.01 0.01 0.02
Price to Operating Income
71.60 29.64 0.00 0.00 77.41 21.84 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.06 0.07 0.09 0.07 0.29 0.22 0.15 0.17 0.21 0.44
Cash ROIC
(31.33%) (12.11%) (21.18%) (27.75%) 4.90% (46.30%) (81.33%) (40.21%) (18.42%) (8.68%)
Accounts Receivable Turnover
10.60 12.56 9.10 8.61 8.58 8.78 13.91 14.60 16.10 22.92
Accounts Payable Turnover
6.97 4.71 4.67 5.83 7.30 5.75 5.90 8.24 10.10 12.82
Inventory Turnover
2.37 2.39 3.12 3.88 3.98 3.23 4.13 6.01 7.99 10.52
Average Days of Payables
32.52 91.79 77.53 80.21 62.62 69.70 64.49 53.83 43.95 32.37
Days of Inventory on Hand
146.88 204.58 124.23 111.41 107.03 142.29 94.23 75.06 58.64 37.36
Average Receivables
5.85 4.17 4.10 4.34 3.43 1.95 0.90 0.97 0.77 0.47
Average Payables
6.60 7.68 6.31 4.96 2.85 1.94 1.68 1.32 0.85 0.59
Average Inventory
19.39 15.15 9.44 7.47 5.22 3.45 2.40 1.81 1.08 0.72
Average Assets
50.03 41.44 33.22 30.98 20.97 11.46 7.97 6.42 5.55 4.71
Average Common Equity
16.29 8.42 3.78 6.56 5.10 2.12 1.45 2.31 3.01 2.83

Fold the line items

Columns are period end dates